Replies to post #402171 on Anavex Life Sciences Corp (AVXL)

[JWC3]

You are addressing total BS from MIKE! The real facts that will quickly drive revenues for ANAVEX are:

1. Approval for A 2-73 for ALZHEIMERS in AUSTRALIA.
2. Approval for A 2-73 for ALZHEIMERS in EUROPEAN UNION, and UNITED KINGDOM ( BRITAIN & CANADA ). This can and probably will occur in MAY 2023.
3. Approval for A 2-73 for RETT SYNDROME in the UNITED STATES in JULY 2023, two months after EXCELLENCE TRIAL reports TLR! Also, award of $100M voucher from FDA.
4. Approval for A 2-73 for A 2/73 for ALZHEIMERS in the UNITED STATES in August 2023!

Net result ANAVEX ROCKETS TO $100+ in June 2023!